We demonstrate that IL-17RC is critically required for maintaining basal levels of the ubiquitin-editing enzyme A20, which represses homeostatic proliferation of tumor cells in a JNK1/JNK2 isoform-dependent manner. This evidence concerns the gene MAPK9 and neoplasm.